Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chongqing Primary Aldosteronism Study

NCT03224312 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.

NCT NCT03224312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03224312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chongqing Primary Aldosteronism Study
Lead sponsor
Chongqing Medical University
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2016
Completion date
December 31, 2028
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism